New ProEducar’s 113 Newsletter

The new ProEducar Educational Newsletter is out for all fellows, interventional trainees, and specialists in hemodynamics seeking to be up to date in their professional practice.

ProEducar Oclusión Total Crónica

This is a special issue on chronic total occlusion (CTO), one of the main current challenges for interventional cardiologists. This comprehensive, extensive work directed by Dr. Gustavo Pedernera includes review articles, relevant clinical cases, interviews to experts, and step-by-step techniques developed by world-renowned Latin American interventional cardiologists.

The newsletter encompasses from revascularization indications to complex revascularization techniques.

Dr. Mario Araya and Dr. Christian Backhouse Q. summarize revascularization indications, and Dr. Marcelo Abud comments on one of the latest articles on current evidence and the benefits of CTO PCI.


Read also | ProEducar’s Newsletter 112: Bifurcations.


The technical focus includes the implementation of a hybrid algorithm assessment, by Dr. Antonio Carlos Botelho and Dr. Alexandre Schaan de Quadros, antegrade approach with wire escalation, by Dr. Carlos Uribe and Dr. Mauricio Zuñiga, dissection and re-entry, by Dr. Ricardo Santiago, and retrograde approach, by Dr. João Tinoco de Paula. These techniques are illustrated through a very challenging clinical case featuring an excellent resolution, by Dr. Andrés Navarro.

Then, Dr. De La Torre summarizes occasional complications and their management.

Finally, there is an interview to Dr. Lucio Padilla on pivotal points for the emergence of a CTO revascularization program and future perspectives in Latin America.


Read also | ProEducar’s Newsletter 111: Unresolved Issues in TAVI.


The ProEducar Newsletter is the result of joint efforts driven by SOLACI and fostered by many Latin American interventional cardiologists who contribute to building a permanent training program for all professionals who want to stay updated and perfect their knowledge and skills in the field of interventional cardiology.

Discover Newsletter #113HERE


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....